January 3, 2025 – Newly updated tuberculosis (TB) treatment guidelines were published in the American Journal of Respiratory and Critical Care Medicine, “Updates on the Treatment of Drug Susceptible and Drug Resistant Tuberculosis: An Official ATS/CDC/ESR/IDSA Clinical Practice Guidelines.” These guidelines introduce shorter, safer, and more effective treatment regimens for patients diagnosed with TB disease.
December 13, 2024 – TAG releases a new report on TB Research Funding Trends (2005 – 2023). The report presents new data on funding for TB R&D in 2023, analyzes trends in spending since 2005, and takes a close look at funding for research to develop new TB vaccines.
December 9, 2024 – DTBE released a DCL on the continued supply interruption of the BD BACTEC™ MGIT™ 960 PZA kits. These kits will not be available for shipment until early 2025. Read more about this and the assignments of labs to which samples can be submitted for testing until the issue is resolved here.
October, 2024 – The Association of Refugee Health Coordinators (AHRC) released an overview of U.S. Refugee Admissions Tracks & Health Considerations. This document can be found on the NTCA website under Resources/New Arrivals or at this link.
October 29, 2024 – The World Health Organization (WHO) released the Global Tuberculosis Report 2024. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. The 2024 report, and reports from prior years, can be accessed here.
